ft 03 jun 92 uk compani news british biotechnolog pathfind publish british biotechnolog group yesterday publish pathfind prospectu intern share offer plan juli oxford base pharmaceut compani say aim rais pound 30m sell 20 per cent equiti share issu london new york issu expect price 400p 450p valu compani pound 150m british biotechnolog use proce flotat primarili fund research develop programm cover four medic area inflammatori diseas arthriti cancer vascular heart diseas viral infect includ aid two drug undergo earli clinic trial third due begin clinic test august group expect market gener revenu commercialis pharmaceut product least latter half 1990